As new coronavirus mutations are expected to emerge over the next year,leading health experts from across the world have cautioned that thevaccines’ gradual roll-out and uneven delivery could render them ineffective
Seventy-seven scientists from leading research institutions across theworld took part in the study, with about 30% predicting thatsecond-generation vaccinations would be needed in as little as nine monthsunless vaccines are more easily developed and delivered.
More vaccine-resistant mutations are probable as a result of exceedingly“low vaccine coverage” in several nations, particularly developedcountries, according to nearly 90% of the study.
According to The People’s Vaccine Alliance just 10% of people in themajority of developing countries would be vaccinated in the next year ifexisting trends continue.
The coalition demanded that prescription monopolies be broken up and thattechnology be shared in order to increase vaccine stocks as quickly aspossible.
Read Top Stories
According to the study, 66 percent of the researchers conclude that thevirus will mutate in a year or less, and that the remainder offirst-generation vaccinations will be made ineffective.
To speed up manufacturing and delivery of the vaccines around the globe,the partnership urged all pharmaceutical companies operating on COVID-19vaccines to freely share their technologies and intellectual property viathe World Health Organization COVID-19 Technology Access Pool.
Meanwhile, world leaders pressed for a new international treaty to bracefor the next global pandemic – to stop the unsightly vaccine rush that hashindered the COVID-19 response.
